Cargando…

Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease

BACKGROUND: To systematically evaluate the association of MTHFR genetic polymorphisms, maternal folic acid intake, and the time when folic acid intake was started with the risk of congenital heart disease (CHD) and investigated the role of their interaction on infant CHD risk in Chinese populations....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Taowei, Song, Xinli, Liu, Yiping, Sun, Mengting, Zhang, Senmao, Chen, Letao, Diao, Jingyi, Li, Jinqi, Li, Yihuan, Shu, Jing, Wei, Jianhui, Zhu, Ping, Wang, Tingting, Qin, Jiabi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492935/
https://www.ncbi.nlm.nih.gov/pubmed/36160803
http://dx.doi.org/10.3389/fped.2022.939119
_version_ 1784793584158900224
author Zhong, Taowei
Song, Xinli
Liu, Yiping
Sun, Mengting
Zhang, Senmao
Chen, Letao
Diao, Jingyi
Li, Jinqi
Li, Yihuan
Shu, Jing
Wei, Jianhui
Zhu, Ping
Wang, Tingting
Qin, Jiabi
author_facet Zhong, Taowei
Song, Xinli
Liu, Yiping
Sun, Mengting
Zhang, Senmao
Chen, Letao
Diao, Jingyi
Li, Jinqi
Li, Yihuan
Shu, Jing
Wei, Jianhui
Zhu, Ping
Wang, Tingting
Qin, Jiabi
author_sort Zhong, Taowei
collection PubMed
description BACKGROUND: To systematically evaluate the association of MTHFR genetic polymorphisms, maternal folic acid intake, and the time when folic acid intake was started with the risk of congenital heart disease (CHD) and investigated the role of their interaction on infant CHD risk in Chinese populations. METHODS: A case–control study involving 592 CHD cases, 617 health controls, and their mothers was performed. The exposures of interest were single nucleotide polymorphisms (SNPs) of the MTHFR gene, maternal folic acid use, and the time when folic acid use was started. We applied the logistic regression model to explore the strength of association. RESULTS: Our findings showed that mothers lacking folic acid intake had a significantly higher risk of CHD in offspring (aOR = 2.00; 95%CI: 1.34–2.98). Mothers who started to use folic acid from the first trimester of the fetation (aOR = 1.65; 95% CI: 1.22–2.23) or from the second trimester of the fetation (aOR = 7.77; 95% CI: 2.52–23.96), compared with those starting to use folic acid from 3 months previous to the conception, were at a significantly higher risk of CHD in offspring. Genetic variants at rs2066470 (AA vs. GG: aOR = 5.09, 95%CI: 1.99–13.03), rs1801133 (AA vs. GG: aOR = 2.49, 95%CI: 1.58–3.93), and rs1801131 (TG vs. TT: aOR = 1.84, 95%CI: 1.36–2.50; GG vs. TT: aOR = 3.58, 95%CI: 1.68–7.63) were significantly associated with the risk of CHD based on the multivariate analysis. Additionally, statistically significant interactions between maternal folic acid intake and genetic variants of the MTHFR gene at rs1801133 and rs1801131 were observed. CONCLUSION: An association of maternal folic acid intake and the time when intake was started with the risk of CHD in offspring was found. What's more, maternal folic acid fortification may help counteract partial of the risks of CHD in offspring attributable to MTHFR genetic mutations. REGISTRATION NUMBER: http://www.chictr.org.cn/edit.aspx?pid=28300&htm=4, identifier: ChiCTR1800016635.
format Online
Article
Text
id pubmed-9492935
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94929352022-09-23 Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease Zhong, Taowei Song, Xinli Liu, Yiping Sun, Mengting Zhang, Senmao Chen, Letao Diao, Jingyi Li, Jinqi Li, Yihuan Shu, Jing Wei, Jianhui Zhu, Ping Wang, Tingting Qin, Jiabi Front Pediatr Pediatrics BACKGROUND: To systematically evaluate the association of MTHFR genetic polymorphisms, maternal folic acid intake, and the time when folic acid intake was started with the risk of congenital heart disease (CHD) and investigated the role of their interaction on infant CHD risk in Chinese populations. METHODS: A case–control study involving 592 CHD cases, 617 health controls, and their mothers was performed. The exposures of interest were single nucleotide polymorphisms (SNPs) of the MTHFR gene, maternal folic acid use, and the time when folic acid use was started. We applied the logistic regression model to explore the strength of association. RESULTS: Our findings showed that mothers lacking folic acid intake had a significantly higher risk of CHD in offspring (aOR = 2.00; 95%CI: 1.34–2.98). Mothers who started to use folic acid from the first trimester of the fetation (aOR = 1.65; 95% CI: 1.22–2.23) or from the second trimester of the fetation (aOR = 7.77; 95% CI: 2.52–23.96), compared with those starting to use folic acid from 3 months previous to the conception, were at a significantly higher risk of CHD in offspring. Genetic variants at rs2066470 (AA vs. GG: aOR = 5.09, 95%CI: 1.99–13.03), rs1801133 (AA vs. GG: aOR = 2.49, 95%CI: 1.58–3.93), and rs1801131 (TG vs. TT: aOR = 1.84, 95%CI: 1.36–2.50; GG vs. TT: aOR = 3.58, 95%CI: 1.68–7.63) were significantly associated with the risk of CHD based on the multivariate analysis. Additionally, statistically significant interactions between maternal folic acid intake and genetic variants of the MTHFR gene at rs1801133 and rs1801131 were observed. CONCLUSION: An association of maternal folic acid intake and the time when intake was started with the risk of CHD in offspring was found. What's more, maternal folic acid fortification may help counteract partial of the risks of CHD in offspring attributable to MTHFR genetic mutations. REGISTRATION NUMBER: http://www.chictr.org.cn/edit.aspx?pid=28300&htm=4, identifier: ChiCTR1800016635. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9492935/ /pubmed/36160803 http://dx.doi.org/10.3389/fped.2022.939119 Text en Copyright © 2022 Zhong, Song, Liu, Sun, Zhang, Chen, Diao, Li, Li, Shu, Wei, Zhu, Wang and Qin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Zhong, Taowei
Song, Xinli
Liu, Yiping
Sun, Mengting
Zhang, Senmao
Chen, Letao
Diao, Jingyi
Li, Jinqi
Li, Yihuan
Shu, Jing
Wei, Jianhui
Zhu, Ping
Wang, Tingting
Qin, Jiabi
Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
title Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
title_full Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
title_fullStr Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
title_full_unstemmed Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
title_short Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
title_sort association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492935/
https://www.ncbi.nlm.nih.gov/pubmed/36160803
http://dx.doi.org/10.3389/fped.2022.939119
work_keys_str_mv AT zhongtaowei associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT songxinli associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT liuyiping associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT sunmengting associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT zhangsenmao associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT chenletao associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT diaojingyi associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT lijinqi associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT liyihuan associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT shujing associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT weijianhui associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT zhuping associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT wangtingting associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease
AT qinjiabi associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease